In the last decade, the development of third generation bioceramics for Bone Tissue Regeneration has experienced significant progress with the emergence of a new generation of nanostructured materials named mesoporous bioactive glasses (MBG). This new generation of materials, also known as "templated glasses", presents chemical compositions similar to those of conventional bioactive sol-gel glasses and the added value of an ordered mesopore arrangement. This article shows an indepth comparative study of the ordered porous structures of MBGs compared to conventional glasses (melt and solgel) and how these properties influence the bioactivity process. Moreover, the possibility to tailor the textural and structural properties of these nanostructured materials by an exhaustive control of the different synthesis parameters is also discussed. A brief overview regarding the possibility of using these materials as controlled drug delivery systems and as starting materials for the fabrication of 3D scaffolds for bone tissue regeneration is also given.
Introduction
Since Prof. L. L. Hench's discovery of the capacity of certain glasses based in SiO 2 to join the hard tissues through a mechanically strong bond [1] , the development and clinical applications of these bioactive glasses was steadily growing over the past 40 years [2] . Compounds such as 45S5 Bioglass , commercialized as different medical devices (Novamin Tech., Perioglass TM , Novabone TM , etc.) are currently used in both orthopedic and periodontal surgeries, as well as dentin regenerating agents included in toothpastes [3] . In 1991, the incorporation of sol-gel chemistry into the synthesis of bioceramics [4] resulted in a new generation of bioactive glasses, which had a huge potential to develop better implants with osteogenic capabilities [5, 6] . This was based on increased surface properties and porosity derived from the sol-gel route, with respect to melt-prepared glasses [7] [8] [9] . Since then, the advances in this research line have gained an important scientific significance, which is reflected in the numerous review articles published on this issue [7, [10] [11] [12] [13] [14] . Very recently, a new generation of nanostructured glasses called mesoporous bioactive glasses (MBGs) has been developed, exhibiting textural and bioactive characteristics never seen before in melt and sol-gel bioactive glasses, mentioned above [15, 16] . These nanostructured materials are developed due to the incorporation of supramolecular chemistry to sol-gel process, leading to a highly ordered mesoporous arrangement, which result in surface and porosity magnitudes up to five times higher than those obtained by conventional methods. Consequently, MBGs exhibit the greatest in vitro bioactivity kinetics observed so far. However, the clinical scope of these materials is still unknown, because their ordered mesoporous structure also allows the incorporation of osteogenic agents, osteoclastic inhibitors, or antimicrobial agents etc. having a huge potential in the treatment of degenerative bone tissue and infections [15, 17] . Herein, a comparative overview concerning the porous structural features of the MBGs compared to conventional glasses (melt and sol-gel) will be tackled. Special emphasis is put to the synthesis of these MBGs, as well as the main parameters that govern the final textural and structural characteristics. Finally, the possibility to incorporate therapeutic agents for local delivery and the manufacture of 3D scaffolds based on these materials, with high control in the pore architecture, will be also shown.
Silica based ordered mesoporous materials in the biomedical context
Silica-based ordered mesoporous materials (SMMs) were first reported by two independent groups in the early 90s:
The group at Waseda University headed by Kuroda [18] and the group working at Mobil Oil Company headed by Kresge [19] . These materials display features structurally unique, exhibiting order on the mesoscopic-scale (2-50 nm) and disorder on the atomic-scale. The synthesis of mesoporous materials requires surfactants as structure directing agents for the assembly, and subsequent condensation of inorganic SiO 2 precursors. After removing the surfactant by calcination or extraction, SMMs are obtained with outstanding features, such as: (i) stable mesoporous structure, (ii) high surface area (ca. 1000 m 2 /g), (iii) large pore volume (ca. 1 cm 3 /g), (iv) regular and tunable nano-pore size (2-50 nm), (v) homogeneous pore morphology (hexagonal and cubic pores) and (vi) high amount of silanol groups on the surface able to be chemically functionalized. Initially, these SMMs were designed for cat- Figure 1 : TEM images comparing a conventional sol-gel glass and a MBG, respectively, with similar composition. Both glass types exhibit the same amorphous atomic structure in the SiO 2 -CaO-P 2 O 5 system and only in the case of MBG there is an added value concerning the ordered mesoporous arrangement.
alytic purposes offering numerous advantages in the hostguest systems [20] [21] [22] [23] .
In 2001, exploring new applications of SMMs, the research team of Prof. Vallet-Regí had the idea to propose them as drug delivery systems [24] . The results were promising since these materials showed excellent properties to load and subsequently controllably release numerous biological active molecules, ranging from small drugs (200 Da) to large molecules as peptides and proteins (ca. 70 kDa). The molecules can be loaded within the mesopores by adsorption mechanism, using an impregnation method, to be subsequently released via diffusioncontrolled mechanism [25] . Therefore, a new research line was opened, which has had a great scientific impact since then [26] [27] [28] [29] [30] [31] . Currently, sophisticated stimulus-response systems based on SMMs are also being developed, which enable to control the drug release once the target tissue or cell is reached [32] [33] [34] , or also via an external stimulus [35] [36] [37] .
Furthermore, in 2006 the same research group hypothesized that the SMMs may present bioactive behavior [38, 39] , based on the presence of large amount of silanol groups on the surface and their importance in bioactive processes [40] [41] [42] . Thus, bioactivity tests were carried out in vitro in a simulated body fluid (SBF) for three typical SMMs: MCM-41, SBA-15 (both with 2D-hexagonal structure) and MCM-48 (with 3D-cubic structure). However, these pristine materials, which are composed by only SiO 2 , despite exhibiting large amount of SiOH groups on the surfaces due to their elevated surface area and porosity values, don't create sufficient conditions to achieve satisfactory bioactive behavior, showing apatite formation layer kinetics too slow, in comparison with conventional sol-gel glass. Therefore, although the high ordered porosity means an added value over conventional bioactive solgel glasses, no SMMs previously described can improve this bioactive behavior. However, these research works provide a big boost in the bioceramics field for bone regeneration purposes, as it will be described in the next section.
Mesoporous Bioactive Glasses
By definition, a MBG is a nanostructured bioaceramic which shares the same structural and textural properties of SMMs exhibiting ordered mesoporous channels, whose walls consist of a vitreous network of composition SiO 2 -CaO-P 2 O 5 similar to the conventional sol-gel glasses. In this sense, at atomic level these MBGs are very similar Representative scheme illustrating the synthesis of MBGs by combination of sol-gel and supramolecular routes characteristics of bioactive sol-gel glasses and SMMs, respectively. The result of this combination is a mesoporous material with similar composition to conventional sol-gel glasses but with the added value of an ordered mesoporous arrangement, which confer fascinating properties related to bioactive behavior and as drug delivery systems. Surfactant molecules are used in MBG synthesis, which act as structure directing agents. Once the critical micellar concentration (cmc) is reached, the surfactant molecules self-assembly into micelles and next into liquid crystalline mesophase, which serve as a template for the condensation of glass precursor. Finally, the surfactant is removed by calcination or extraction methods, leaving the empty holes and forming the mesoporous structures.
to conventional glasses but with the added value of exhibiting highly ordered mesoporous arrangement of cavities, arranged periodically on lattices like artificial atoms or molecules in ordinary crystals (Figure 1 ). This ordered mesoporous arrangement produces surface area and pore volume significantly larger than those obtained by conventional sol-gel methods with analogous composition [43] .
The research team of Prof. DY Zhao (2004) [44] and Prof. M. [45] were the first research groups that synthesized these mesoporous bioactive glasses. The synthesis of these materials combines the chemical sol-gel of multicomponent SiO 2 -CaO-P 2 O 5 system of bioactive glasses with the supramolecular chemistry using surfactants as structured directing agents. However, the merit of the MBG synthesis is not only attributed to the surfactant addition but also requires new strategies that assure the presence of a multicomponent inorganic system that includes CaO. Figure 2 shows a schematic representation of the synthesis of these materials based on the combination of both sol-gel and supramolecular chemistries.
The success of the synthesis of MBGs is based on the use of evaporation-induced self-assembly (EISA) process [46] . The self-assembly starts with a homogeneous solution of glass precursors and surfactant prepared in ethanol/water with an initial concentration, c 0 << cmc, cmc being the critical micellar concentration. The concentration of the system is progressively increased by the ethanol evaporation which drives the self-assembly of inorganic-surfactant micelles and further organization into a liquid crystalline mesophase.
The use of EISA process is due to two important reasons derived from the incorporation of both sol-gel and supramolecular chemistries as follows: (i) during the synthesis of SiO 2 -CaO-P 2 O 5 sol-gel glass, both gel aging and dried stages involve temperatures around 100 ∘ C [47] , which are incompatible with the establishment of an ordered micellar phase, and (ii) the classical hydrothermal preparation of SMM is not compatible with a multicomponent system, where the presence of CaO could hinder the interactions between silica and surfactant. Therefore, EISA method uses a much diluted precursor solution by using a volatile solvent, such as ethanol, which is gradually evaporated at room temperature until it reaches the cmc, leading to self-assembly of the micelles, arranged in stages more robust from the point of view of structural stability [48, 49] . This synthesis process allows to tailor the textural and structural characteristics and offers numerous advantages in the final features of these materials including the bioactive response. In pure SMMs, the formation of ordered mesoporous arrangement is mainly guided by different parameters, such as surfactant nature and concentration, solvent, additives, pH, temperature, etc., which determine the final structural and textural parameters. Thus, such structures as 2D hexagonal arrangement with p6mm planar group and cage-type 3D-cubic structures with Im3m spacial group can be obtained by using different surfactants as Pluronic P123 and Pluronic F127, respectively [50, 51] . In this sense, 2D hexagonal structures are formed by unidirectional opening channels in both directions, which are distributed in a hexagonal arrangement, and 3D cubic cage-type structures are formed by a bodycentered cubic structure interconnected through opening to form multidirectional mesoporous network [52] .
Furthermore, it is possible to modulate the structure of MBGs from 2D hexagonal structure to 3D bicontinuos cubic structure with Ia-3d space group by using the same surfactant and varying the CaO amount in the SiO 2 -CaO-P 2 O 5 system [45, 53] . Thus it is possible to obtain 3D cylindrical channels instead of unidirectional channels of 2D hexagonal structure, which will result in a different bioactive behavior. Left part of Figure 3 represents this study, carried out by Prof. Vallet-Regí, where one can ob- serve that by decreasing calcium content an evolution in mesoporous structure progresses from 2D-hexagonal to 3D-bicontinuos cubic structure, respectively. It can be explained in terms of the influence of Ca 2+ ions on the silica condensation, as Ca 2+ ions act as network modifiers, decreasing the silica network connectivity. Consequently, the inorganic/organic volume ratio of the surfactant micelle is increased with the calcium content, thus decreasing the curvature of the surfactant micelles and contributing to the formation of hexagonal phases rather than cubic ones.
Moreover, it has also been demonstrated that the evaporation temperature during the EISA process appears to be an effective parameter to control the final mesostructure for a given ternary composition [53] . Therefore, the structural parameters change from 2D-hexagonal structure to 3D-bicontinuous cubic structure with increasing solvent evaporation temperature (Figure 3 right) . When the temperature rises, the micelle size surfactant system shows a significant increase caused by reduced hydrogen interaction between micelles and water as Zhao et al. has previously reported [54] . This reduced hydrogen interaction could be explained by an increased hydrophobicity of polyethylene oxide units of the surfactant. Then, 3D-cubic structure is favored through the decrease of hydrophilic/hydrophobic volume. Therefore, 2Dhexagonal structure is formed at lower temperature while 3D-cubic structure is formed at higher temperature.
As it has been mentioned, the possibility to tailor the pore structure and textural properties at nanometric level allows an exhaustive control of final properties, such as bioactivity/reactivity and capability to load and control release of biologically active molecules. This possibility extends the range of applicability of these materials [15, 16, 55] . In this sense the bioactive process, whereby a material reacts with living tissue, is a phenomenon that begins at the interface between the implant surface and the bone. The amount of matter, which can be disseminated and exchanged between implant and bone, determines the kinetics that takes place between both surfaces. In this sense, this diffusion of material is higher in 3D-cubic structures, as compared to 2D-hexagonal structures, showing higher bioactivity kinetics despite containing lower calcium content. This is probably one of the most notable differences between the conventional glasses and MBGs. In the former, a greater presence of CaO determined a better bioactive behavior. By contrast in MBGs, the textural and structural properties govern largely the bioactive behavior due to an increased diffusion process [56] .
MBGs exhibit better bioactivity than conventional glasses (melt and sol-gel glasses) due to their outstanding surface area and porosity. While melt-prepared glasses exhibit bioactivity after 7 days of soaking in a simulated body fluid (SBF), sol-gel glasses exhibit bioactivity after 3 days and MBGs only after 4 hours. In this sense, there is a current controversy regarding which are the factors that contribute to this great improvement in bioactivity. Although, in part, it is believed that the composition of MBGs plays a predominant role, similar to those found for melt and sol-gel glasses, the enhanced textural properties are recognized to be the dominating factor contributing to the superior in vitro bioactivity, which has been attributed mainly to the highly ordered arrangement of uniform-sized mesopores.
To clarify this controversy, it is important to know the atomic structure of these MBGs and how the local structure affects to the bioactivity. Several studies using advanced characterization techniques, including highresolution TEM (HRTEM) and solid-state nuclear magnetic resonance (NMR), have determined the complex amorphous structure on the atomic scale for all the types of glasses [57] [58] [59] [60] [61] [62] . The results have shown that melt, sol-gel and mesoporous bioactive glasses containing phosphorous and calcium in their composition, exhibit two different domains: (i) an amorphous SiO 2 -CaO-(Na 2 O) phase and (ii) calcium phosphate clusters embedded into the amorphous phase.
The amorphous SiO 2 -CaO-(Na 2 O) component is mainly formed by an interconnected network of SiO 4 tetrahedra with network modifier cations (such as Na + or Ca 2+ ) which break the Si-O-Si linkages. The structural building blocks of silicates are commonly described using the Qn notation, where n denotes the number of bridging oxygen (BO) atoms at the SiO 4 tetrahedron, leaving (4-n) positions oc- cupied by non-bridging oxygen (NBO) ions. An increase in the network modifiers provokes a decrease in the network connectivity, increasing the NBO units in the three families of glasses [63] [64] [65] . In this sense, it has been demonstrated that a decrease in the glass connectivity provokes an increase in the bioactivity with respect to melt and sol-gel glasses. However, when comparing sol-gel with MBGs, the connectivity rate for both is very similar, where the 29 Si NMR studies showed analogous distribution of Q units, that is, Q 4 , Q 3 , and Q 2 units [56] . Therefore, the silica environment cannot explain the accelerated bioactive behavior of MBG with respect to sol-gel glasses. In this sense, this behavior can be explained at the nanoscopic length scale, as the ordered mesoporous arrangement provokes outstanding textural properties which notably increase the accessibility of the surrounding medium to the silica environment, as reported previously [57] . Concerning the calcium phosphate component, NMR and HRTEM studies have reported that the joint presence of calcium and phosphorous in the three glass types provokes the formation of calcium phosphate clusters, which are embedded in the SiO 2 -CaO-(Na 2 O) amorphous network [66] . A schematic picture concerning P structural role in bioactive glasses is shown in Figure 4 . HRTEM studies in sol-gel glasses showed the presence of small domains of a crystalline phase, composed by Ca and P, inside the amorphous SiO 2 -CaO network. These Ca-P clusters may act as nucleation sites that increase the crystallization kinetics of the HCA layer, as previously reported by NMR results. In the case of MBGs, initial studies based on HRTEM coupled with energy dispersive X-ray spectroscopy (EDS) showed a homogeneous elements distribution over tens of nanometers (44, 45) . However, a deep study by NMR clarified the presence of domains of amorphous calcium phosphate (ACP) homogeneously distributed at the pores wall, which cannot be observed by HRTEM (Figure 4 ). In the case of MBGs, there is a high accessibility of these nuclei sites due to high surface area and pore volume, which could explain the outstanding bioactive behavior of these materials [56, 67] .
Undoubtedly, the possibility of developing bioceramics with ordered mesoporous structures has represented a significant advance for the scientific biomaterials community [15] due to the fact that these bioceramics exhibit bioactivity very fast -in terms of hours instead of 3 days for conventional sol-gel glasses. To summarize, the Figure 5 displays the main differences between the MBGs and conventional melt and sol-gel glasses.
Possibility of controlled release of drugs from mesoporous bioactive glasses
The rapid development of controlled drug release systems based on SMMs has facilitated the incorporation of such properties to MBGs. Because they keep the excellent surface properties and porosity, as well as the ability to be functionalized, several research groups understood high potential of MBGs, as due to their excellent bioactive behavior they could act as release systems for antibiotics and/or osteogenic agents. One of the most common and difficult problems to solve in orthopedic surgery is the bone infection. The incidence of osteomyelitis caused mainly by S. epidermidis and S. aureus is relatively high. The problem is compounded when these microorganisms are capable of developing a biofilm on the implant surface. At that time, systemic administration of antibiotics is very effective and the most common solution is the implant replacement due to septicemia. In this sense, the local and controlled administration of antibiotics from the implant should represent an excellent alternative in case of infection. Xia and Chang [68, 69] first proposed the incorporation of antibiotics within the porous structure of the MGBs. To do this, they applied the conventional impregnation method of the drug, by soaking a MBG composed of %mol 58 SiO 2 :37 P 2 O 5 :5 CaO with concentrated solution of gentamicin sulfate. It was demonstrated that MBG could incorporate up to 3 times larger amount of gentamicin than conventional sol-gel glass with similar composition. Moreover, the kinetics release profile of gentamicin can be explained according to the model in which the antibiotic molecules can occupy different positions in the pore, establishing different release kinetics for each of these positions.
In the case of MBGs, the load and release of the drug are dependent not only on the porosity, but also on the chemical composition, as it was reported elsewhere [70, 71] . For example, tetracyclines' adsorption depends on calcium content of MBG, which acts as a chelating agent in the pore wall. For the same reason, the release kinetics slows down with increasing CaO content, because of the affinity of tetracycline to calcium in the structure. Moreover, a study was performed on drug loading and release properties with various structure-directing agent, specifically P123 and F127, establishing differences as function of textural properties of each MBG [72] . However, even considering the importance of textural features in control of drug release, the previous experience with silica mesoporous materials had shown that this control required to functionalize the surfaces of the porous matrices. Otherwise, the immediate release of drug and the inability to obtain zero order release kinetics limited the use of these matrices. However, the functionalization of MBGs may be difficult due to the possible loss of bioactivity by modifying their surface [73] . Only recently a systematic study has been carried out on how different functionalizing agents determine the control of the release of ipriflavone without significantly altering the bioactive nature of these materials [74] . By functionalization with thiol groups, amino, hydroxyl and phenyl, it was possible to obtain zero-order kinetics. The kinetic constants could be controlled depending on the strength of the hydrogen bonds that were established between the drug and different functional groups ( Figure 6 ).
Moreover, like SMMs, MBG can also become drug delivery matrix for large molecules, such as vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP), which have been incorporated into mesoporous channels showing a high loading efficiency and effective release of these molecules [75] .
Beyond the porosity of these MBGs, one of the most important aspects is the morphology and particle size of the material. In this sense, many researchers have considered to control these parameters to design more effective drug delivery systems [75] . Among them, the microsphere preparation of controlled size has caught the attention of different groups [76] [77] [78] [79] . These microspheres have sizes between 100 nm and 1 micrometer and are obtained at the SiO 2 -CaO-P 2 O 5 system using the surfactant P123 as the structure directing agent. The methods to obtain MBG microspheres vary. Among them, Aerosol assisted method is the most important, with the evaporation induced self-assembly with the formation of small droplets containing all precursors of MBG microspheres. Some of these microspheres have been proposed as bone graft and drug delivery systems [77] . A second strategy for the fabrication of microspheres is by using the precipitation in basic medium from a dilute solution of the surfactant and precursors. This method results in smaller and monodispersed spheres, but presents problems of agglomeration [79] . Obtaining monodispersed small micro- spheres allows their possible incorporation into the blood system due to the fact that the hydrodynamic stability in the circulation is achieved when the carrier particle size is maintained between 50 and 300 nm. Oversized particles are retained in the lung and liver, and those with smaller sizes up to 50 nm can pass through the vascular endothelium and be distributed in the body nonspecifically. In this sense, mesoporous CaO-SiO 2 nanospheres have been prepared. In this case the CaO plays a role in promoting biodegradation, favoring a process of bone formation.
Recently, MBGs ultrafine hollow fibers have been prepared by electrospining techniques [80] . These results presented the formation of hollow fibers with mesoporous structures in the walls, which exhibit the ability to load and control the release of gentamicin sulfate as function of length of the fiber, thus presenting excellent bioactive properties.
Currently, stimulus-response systems based on MBGs are being explored but until now there have been few works in this field [81, 82] . These systems consist of molecular nano-gates, which allow the opening and closing of the mesopores, whose control is subjected to an external stimulus (light, magnetic field, etc. . . ). Lin and colleagues have developed a system of molecular gates based on photodimerization of coumarin molecule [83] . These systems act by UV irradiation with a wavelength above 310 nm which induces dimerization of coumarin, closing the opening of mesopores and preventing drug-diffusion.
Potential scaffolds based on mesoporous bioactive glass for Bone Regenerative therapies
The regeneration of critical bone defects is probably the most important and difficult challenge that is tackled by the 3 rd generation biomaterials. In the case of small bone defects, such as those typically derived from periodontal surgery, the implant can be performed from granulesshape, or form a paste with saline serum or blood. However, the regeneration of a critical defect requires pieces, which should be fitted to it. In many cases, the implantation supports excessive mechanical loads, which limit the use of most types of ceramic materials. Moreover, the implants must exhibit pores large enough to allow colonization by osteoblasts and facilitate angiogenesis [84] [85] [86] . For all these reasons it is easy to understand the magnitude of the problem, which is tackled by the use of MBGs in bone regenerative therapies.
The first attempt to mold shaped pieces based on MBGs was performed by the team of Prof. Stucky [87] . This group prepared an injectable paste by mixing SiO 2 -CaO-P 2 O 5 MBG with a buffered solution of ammonium phosphate. This paste set in a similar way to calcium phosphate cements, allowing the formation of pieces with high mechanical strength and bioactive behavior. However, these materials did not have a designed macroporous architecture required for a scaffold aimed at regeneration, exhibiting a random macroporosity and poor interconnectivity.
The pioneering team in incorporation of MBGs to the scaffold fabrication methods was the group of Prof. Yun [88] . This group incorporated the rapid prototyping techniques for the preparation 3D macroporous scaffolds based on MBGs by CAD files. Moreover, these scaffolds can also act as drug delivery systems, since they retain their ordered mesoporous structure. Scaffolds obtained by rapid prototyping technique have the particularity to contain three different pore systems on nanometer, micrometer and macroscopic scales, all with a strict controlled size and porous systems. For this, the combination of a surfactant (P123 and F127) as structure directing agent to generate ordered mesoporosity (see section 2), a polymer, such as methylcellulose which generates pores in the micrometer range, and finally a macroporous architecture designed by rapid prototyping techniques, is required. Figure 7 represents a different ranges of porosity obtained by this technique.
However, the main problem of these 3D macroporous ceramic scaffolds is their extreme fragility, which limits their application in orthopedic surgery. While it has been demonstrated that the formation of an apatite type phase reinforces the mechanical properties of the scaffolds based on MBGs, this increase does not satisfy the mechanical requirements for bone application [89] . For this, the combinations of MBGs with biocompatible polymers, such as polycaprolactone (PCL), has been proposed [90, 91] . These 3D scaffolds based on ceramic-polymer composite have given excellent results in terms of mechanical improvement, keeping their bioactive properties under in vitro conditions. Biocompatibility tests in vitro using osteoblastic lines showed increased cell adhesion and proliferation on these compound scaffolds in comparison with those manufactured only with PCL. Excellent cell biocompatibility was subsequently confirmed [92] [93] [94] [95] [96] .
Furthermore, the macroporous architecture of these 3D scaffolds can also be designed from polymers which constitute a readily removable template by calcination [97] . This methodology has also been employed using polyurethane sponge [98, 99] which, after being calcined, yields pieces highly porous with high pore interconnectivity, very similar to trabecular bone structures.
Future perspectives
New regenerative therapies in the field of bone disease require synergy between materials science and pharmaceutical sciences. In the last decade we have observed a radical change in strategy of biomaterial designing, which is addressed to bone tissue diseases. The idea is not aimed at substitutive therapies but at designing materials that mimic the bone physiological functions. The first option has important limitations to the lifespan of the implant and the second involves goals which are far from being achieved yet.
A more realistic approach, but no less ambitious, is to provide a platform which encourages self-healing mechanisms. In this sense, the MBGs could play the roles of local drug delivery systems and 3D scaffolds for bone regeneration.
The synergy between pharmaceutical sciences and bioceramics requires very specific surface features and porosity. By incorporation of supramolecular chemistry to the sol-gel technology, together with the design of 3D scaffolds by rapid prototyping techniques, it is possible to obtain hierarchical meso-macroporus implants, where each porosity level exerts a different functionality. In this sense, macroporous architecture will tackle requirements for bone tissue regeneration purposes and the mesoporous arrangement will address the issue of load and release of biological active molecules, among these the antibiotic, anti-resorptive and stimulating osteoblastic agents. In this sense, MBGs present a good strategy to solve the problems caused by the loss of bone tissue [100] .
Conclusions
Mesoporous bioactive glasses constitute a new generation of nanostructured bioceramics with outstanding bioactive behavior, as compared with conventional bioactive glasses (melt and sol-gel bioactive glasses), where the ordered arrangement of the mesoporous structure is combined with the structural disorder of glassy materials. Although the composition of these materials is very similar to conventional sol-gel glasses, and both exhibit a silica network with small domains of calcium phosphate homogenously distributed into the pore wall surface, the superior in vitro bioactivity behavior of MBGs mainly lies in the enhanced textural properties (higher surface area and pore volume than the conventional ones) which have been attributed to the highly ordered arrangement of uniform sized mesopores.
It has been verified that the ability to tailor the textural and structural properties of these nanostructured materials at the nanometer scale offers numerous advantages in the control of bioactivity. Moreover, the ordered mesoporous arrangement offers the possibility to use such nanostructured bioceramics as local drug delivery systems for the treatment of bone pathologies and complex diseases, offering promising solutions for biomedical applications. Finally, the possibility to shape these mesoporous glasses in 3D scaffolds with high control of pore architecture, keeping the mesostructural properties, open new possibilities as materials in bone tissue regeneration.
